跳至主要内容
临床试验/NCT02007915
NCT02007915终止不适用

The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral Head

The Hospital for Sick Children1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
20
试验地点
1
主要终点
Avascular necrosis

研究概览

简要总结

To determine the safety and effectiveness of pamidronate in patients with radiographically proven avascular necrosis which are the result of unstable (acute) slipped capital femoral epiphysis, traumatic proximal femur fractures, traumatic hip dislocations, or idiopathic in nature.

详细描述

Avascular necrosis of the femoral head and collapse is a devastating condition in the pediatric patient population leading to degenerative arthritis and significant disability. Bisphosphonate therapy has been shown to be effective in the treatment of adults with avascular necrosis of the femoral head. For children and adolescents however, there is currently no effective treatment that prevents collapse of the femoral head. Some patients with proven avascular necrosis of the femoral epiphysis are treated with bisphosphonates (intravenous pamidronate) at the The Hospital for Sick Children. The main aim of this study is to prospectively collect data on HSC patients receiving bisphosphonate treatment and thereby report the effectiveness of this treatment in the prevention of femoral head collapse.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 10 and 18 with:
  • unstable slipped capital femoral epiphysis (defined as inability to bear weight) or acute slipped capital femoral epiphysis (defined as a separation of the epiphysis from the metaphysis of the proximal femur) who have been pinned either in situ or following reduction,
  • traumatic hip dislocations or traumatic proximal femur fractures, or
  • "idiopathic" avascular necrosis of the femoral head which includes unknown causes as well as Sickle Cell Disease, post radiation use, post chemotherapy treatment, and post steroid treatment.

排除标准

  • Decline to participate in study. (Patients will be still offered this therapy whether or not they wish to be included in the official study protocol. Clinical evaluations, laboratory and imaging tests would be unchanged if they choose to be treated with intravenous pamidronate)
  • Significant femoral head collapse - judged radiographically by treating surgeon
  • Idiopathic causes under the age of 10.

研究组 & 干预措施

Pamidronate Disodium

Experimental

干预措施: Pamidronate Disodium (Drug)

结局指标

主要结局

Avascular necrosis

时间窗: 2 years

Prevention of femoral head collapse and the degree of avascular necrosis following treatment with bisphosphonates as determined clinically and radiographically

次要结局

  • Activities Scales for Kids (ASK)(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James Wright

Surgeon-in-Chief & Chief of Perioperative Services

The Hospital for Sick Children

研究点 (1)

Loading locations...

相似试验